#151178

Anti-L1CAM [UJ127.11]

Cat. #151178

Anti-L1CAM [UJ127.11]

Cat. #: 151178

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-5 days

Target: L1 cell adhesion molecule (L1CAM; CD171)

Class: Monoclonal

Application: ELISA ; FACS ; IHC ; IF ; IP ; WB

Reactivity: Human ; Mouse

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: John Kemshead

Institute: Institute of Child Health

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-L1CAM [UJ127.11]
  • Alternate name: CAML1, HSAS1, Hyd, L1 Cell Adhesion Molecule, L1-NCAM, MASA, MIC5, NCAM-L1, Nerve-growth factor-inducible large external glycoprotein, Neural cell adhesion molecule L1, NILE, S1, SPG1
  • Research fields: Cell biology;Cell signaling and signal transduction;Neurobiology
  • Clone: UJ127.11
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 220-240 kDa
  • Strain: Balb/c
  • Reactivity: Human ; Mouse
  • Host: Mouse
  • Application: ELISA ; FACS ; IHC ; IF ; IP ; WB
  • Description: Monoclonal antibody capable of differentiating between brain tumours of neural origin rather than glial origin.
  • Immunogen: Homogenous suspension of 16 week human foetal brain.
  • Immunogen uniprot id: P32004
  • Isotype: IgG1 kappa
  • Myeloma used: P3X63Ag8.653
  • Recommended controls: Frozen mouse E16.5 lung sections (IHC), Cell lines TR 14, LAN-1, CHP 100, CHP212, CHP126 ( Neuroblastomas or Schwannomas) (IF), M5 melanoma cells or human foetal brain (WB)

Target Details

  • Target: L1 cell adhesion molecule (L1CAM; CD171)
  • Molecular weight: 220-240 kDa
  • Tissue cell line specificity: Frozen mouse E16.5 lung sections (IHC), Cell lines TR 14, LAN-1, CHP 100, CHP212, CHP126 ( Neuroblastomas or Schwannomas) (IF), M5 melanoma cells or human foetal brain (WB)
  • Target background: Anti-L1CAM (UJ127.11) recognises L1 cell adhesion molecule (L1CAM), a cell-surface glycoprotein of 220-240kDa (doublet) and member of the neural adhesion molecule family of the immunoglobulin superfamily. UJ127.11 may be useful in the diagnosis of embryonic tumours (e.g. neuroblastoma) or for the purpose of bone marrow purging. Studies on normal foetal and adult tissues show that UJ127:11 recognises antigen restricted in its expression to cells of neural rather than glial origin. Neural tumours such as neuroblastoma, medulloblastoma, schwannomas and ganglioglioma bind the monoclonal antibody whereas malignancies originating from glial cells do not bind UJ 127:11 this allows for diagnosis of the origin of brain tumour. This antibody has little cross-reactivity with tissues outside of the neuroectoderm. L1CAM is implicated in the development of the nervous system and its expression is restricted to tissues arising from the neuroectoderm. L1CAM is present on tumours of neuroectodermal and glial origin (e.g. neuroblastoma and schwannomas). L1CAM also plays an important role in axon growth, fasciculation, neural migration and in mediating neuronal differentiation. Expression of L1 protein is restricted to tissues arising from neuroectoderm.

Applications

  • Application: ELISA ; FACS ; IHC ; IF ; IP ; WB

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: Store at -20° C frozen. Avoid repeated freeze / thaw cycles
  • Shipping conditions: Shipping at 4° C

References

  • Maten et al. 2019. Int J Mol Sci. 20(17):. PMID: 31455004.
  • Pace et al. 2019. Int J Mol Sci. 20(16):. PMID: 31426278.
  • Stevers et al. 2019. Mod Pathol. 32(1):88-99. PMID: 30171198.
  • Wang et al. 2018. Neurobiol Dis. 116:53-59. PMID: 29705185.
  • Er et al. 2018. Nat Cell Biol. 20(8):966-978. PMID: 30038252.
  • Zaatiti et al. 2018. Int J Oncol. 52(3):787-803. PMID: 29328367.
  • Wood et al. 2018. Brain Pathol. 28(2):192-202. PMID: 28960623.
  • Fontanals-Cirera et al. 2017. Mol Cell. 68(4):731-744.e9. PMID: 29149598.
  • Agrawal et al. 2017. Cancer Cell. 31(6):804-819.e7. PMID: 28609658.
  • Lund et al. 2015. PLoS One. 10(4):e0123684. PMID: 25860483.
  • Slug-dependent upregulation of L1CAM is responsible for the increased invasion potential of pancreatic cancer cells following long-term 5-FU treatment.
  • Matsuda et al. 2013. J Proteomics. 85:1-11. PMID: 23612463.
  • Glycoproteomics-based cancer marker discovery adopting dual enrichment with Wisteria floribunda agglutinin for high specific glyco-diagnosis of cholangiocarcinoma.
  • Morales et al. 2012. Mol Cell Proteomics. 11(6):M111.011973. PMID: 22186713.
  • Alterations in protein regulators of neurodevelopment in the cerebrospinal fluid of infants with posthemorrhagic hydrocephalus of prematurity.
  • Heiz et al. 2004. J Biol Chem. 279(30):31149-56. PMID: 15151998.
  • Hepatocyte growth factor-induced ectodomain shedding of cell adhesion molecule L1: role of the L1 cytoplasmic domain.
  • Patel et al. 1990. Biochem Soc Trans. 18(2):274. PMID: 2379713.
  • Monoclonal antibody UJ127.11 recognizes the human homologue of mouse L1 cell adhesion molecule.
  • Kemshead et al. 1983. Int J Cancer. 31(2):187-95. PMID: 6826247.
  • Monoclonal antibody UJ 127:11 detects a 220,000-240,000 kdal. glycoprotein present on a sub-set of neuroectodermally derived cells.